A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

NCT06223360 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

406

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Low Dose Benfotiamine
DRUG: High Dose Benfotiamine
DRUG: Placebo

Sponsor

Alzheimer's Disease Cooperative Study (ADCS)

Collaborators

[object Object]
[object Object]